Genetic variation associated with thyroid autoimmunity shapes the systemic immune response to PD-1 checkpoint blockade.

Nature Communications
Zia KhanG Scott Chandler

Abstract

Activation of systemic immune responses using PD-1 checkpoint inhibitors is an essential approach to cancer therapy. Yet, the extent of benefit relative to risk of immune related adverse events (irAE) varies widely among patients. Here, we study endocrine irAE from 7 clinical trials across 6 cancers where atezolizumab (anti-PD-L1) was combined with chemotherapies and compared to standard of care. We show that atezolizumab-induced thyroid dysfunction is associated with longer survival. We construct a polygenic risk score (PRS) for lifetime risk of hypothyroidism using a GWAS from the UK Biobank and apply this PRS to genetic data collected from 2,616 patients of European ancestry from these trials. Patients with high PRS are at increased risk of atezolizumab-induced thyroid dysfunction and lower risk of death in triple negative breast cancer. Our results indicate that genetic variation associated with thyroid autoimmunity interacts with biological pathways driving the systemic immune response to PD-1 blockade.

References

Aug 2, 2007·American Journal of Human Genetics·Jon Wakefield
Sep 17, 2010·Cancer·Manuela SchmidingerChristoph C Zielinski
Apr 12, 2012·PloS One·Nicholas ErikssonChuong B Do
Jan 22, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hansje-Eva TeulingsRosalie M Luiten
Feb 13, 2015·Nature Reviews. Cancer·Eric C DietzeVictoria L Seewaldt
Mar 24, 2015·Trends in Immunology·Kristen E Pauken, E John Wherry
Oct 9, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Morganna Freeman-KellerJeffrey Weber
Nov 3, 2016·The New England Journal of Medicine·Douglas B JohnsonJavid J Moslehi
Jan 20, 2017·Nature·Daniel S Chen, Ira Mellman
Jan 21, 2017·Nature Reviews. Endocrinology·David J ByunMonica Girotra
Mar 25, 2017·Lancet·Layal ChakerRobin P Peeters
Apr 4, 2017·American Journal of Human Genetics·Alicia R MartinEimear E Kenny
May 6, 2017·Nature Medicine·Carl H JuneJeffrey A Bluestone
Jan 11, 2018·The New England Journal of Medicine·Michael A PostowMatthew D Hellmann
Feb 15, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Julie R BrahmerUNKNOWN National Comprehensive Cancer Network
Jun 5, 2018·The New England Journal of Medicine·Mark A SocinskiUNKNOWN IMpower150 Study Group
Sep 2, 2018·Nature Reviews. Rheumatology·Leonard H CalabreseLaura C Cappelli
Oct 4, 2018·The New England Journal of Medicine·Leora HornUNKNOWN IMpower133 Study Group
Oct 23, 2018·The New England Journal of Medicine·Peter SchmidUNKNOWN IMpassion130 Trial Investigators
Oct 28, 2018·Nature Communications·Alexander TeumerMarco Medici
Jan 1, 2019·American Journal of Human Genetics·Gleb KichaevAlkes L Price
May 28, 2019·Seminars in Cancer Biology·Ilaria Muller, Peter J Barrett-Lee
Dec 10, 2019·Thyroid : Official Journal of the American Thyroid Association·Anupam KotwalMabel Ryder
Mar 7, 2020·Nature Genetics·Melinda C Mills, Charles Rahal
Apr 18, 2020·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Robert JotteMark A Socinski
May 21, 2020·Proceedings of the National Academy of Sciences of the United States of America·Zia KhanMatthew L Albert
Dec 17, 2020·Bioinformatics·Florian PrivéBjarni J Vilhjálmsson

❮ Previous
Next ❯

Software Mentioned

COJO
LDpred2
SNPRelate R
GCTA
SAIGE
auto
coxme
ADMIXTURE
Lasso
DIAGRAM

Related Concepts

Related Feeds

Breast Cancer: Therapeutic Approaches

Several different therapeutic approaches are used to treat breast cancer. These include chemotherapy, hormonal therapy, targeted therapy, and Immunotherapy. Discover the latest research on breast cancer therapeutic approaches here.

Autoimmune Thyroiditis

Autoimmune thyroiditis is an inflammatory disease of thyroid gland due to autoimmune responses leading to lymphocytic infiltration of the gland. It is characterized by the presence of circulating thyroid antigen-specific T-cells and thyroid autoantibodies. Discover the latest research on autoimmune thyroiditis here.